About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

LOGIN
My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Diabetes Technology & Therapeutics

Editor-in-Chief: Satish K. Garg, MD

ISSN: 1520-9156 • Published Monthly • Online ISSN: 1557-8593

Current Volume: 16

Latest Impact Factor* is 2.205

*2012 Journal Citation Reports® published by Thomson Reuters, 2013

Featured Press Releases and Editorial Content

Overview

Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of the latest technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.

Diabetes Technology & Therapeutics coverage includes:

  • Detection and prevention of long-term micro- and macrovascular complications
  • Breakthrough technologies and new therapeutic drug classes
  • Behavioral aspects and approaches to diabetes care
  • The latest advancement and applications of new and emerging technologies, including:
    • Alternate insulin delivery methods
    • Continuous glucose monitoring
    • Artificial pancreas
    • Computerized case management/telemedicine
    • New insulins with ultra-rapid onset of action
    • Detection and prevention of hypoglycemia

Diabetes Technology & Therapeutics is under the editorial leadership of Editor-in-Chief Satish K. Garg, MD, University of Colorado Denver, Barbara Davis Center for Childhood Diabetes; Senior Editors Jay S. Skyler, MD, MACP, University of Miami Miller School of Medicine, and Irl B. Hirsch, MD, University of Washington Medical Center–Roosevelt; and other leading investigators. View the entire editorial board.

Audience: Endocrinologists, pediatricians, family practice physicians, nurse practitioners, diabetes clinics, and diabetes equipment manufacturers, among others

Society Affiliation

  The Official Journal of the Advanced Technologies & Treatments for Diabetes (ATTD) Conference

 

Indexed/Abstracted in:

MEDLINE; PubMed; PubMed Central; Current Contents®/Clinical Medicine; Science Citation Index Expanded; Journal Citation Reports/Science Edition; Prous Science Integrity®; EMBASE/Excerpta Medica; Scopus; Elsevier BIOBASE-Current Awareness in Biological Sciences (CABS); EMCare; CINAHL® database
 

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Metabolic Syndrome
    and Related Disorders

    Metabolic Syndrome
    and Related Disorders

    The only peer-reviewed journal focusing solely on the pathophysiology, recognition, and treatment of this major health condition.

    Childhood Obesity

    Childhood Obesity

    Explores effective, actionable strategies for weight management and obesity prevention in children and adolescents, with in-depth coverage on education, policy, health disparities and cultural sensitivities, and more.

    Population Health Management

    Population Health Management

    Comprehensive, authoritative strategies for improving the systems and policies that affect health care quality, access, and outcomes, ultimately improving the health of an entire population.

Browse All Publications »


ATTD launches brand new Diabetes Technology Connection newsletter!